Overview

A Thorough QT Study of TR-701free Acid (FA) in Healthy Subjects

Status:
Completed

Trial end date:
2011-12-23

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the effects of oral TR-701 free acid (FA) versus placebo on QTcF.

Phase:

Phase 1

Details

Lead Sponsor:

Trius Therapeutics LLC

Treatments:

Fluoroquinolones
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
Oxazolidinones
Tedizolid
Tedizolid phosphate
Torezolid
Torezolid phosphate